Degradative enzyme systems in osteoarthritic cartilage

Area of Science:

• Biochemistry
• Orthopedics
• Rheumatology

Background:

• Osteoarthritis (OA) is characterized by cartilage matrix degradation despite increased synthesis.
• Key matrix components like proteoglycan and collagen are reduced in OA cartilage.
• This reduction is hypothesized to stem from enhanced intrinsic degradative activity within the cartilage.

Purpose of the Study:

• To investigate the role of enhanced degradative enzymes in osteoarthritis.
• To correlate enzyme levels with disease severity using histologic controls.
• To evaluate the therapeutic potential of enzyme inhibitors, specifically EDTA, in an OA model.

Main Methods:

• Histologic analysis to assess OA severity across different cartilage areas and specimens.
• Quantification of neutral proteoglycanase, collagenase, and acid phosphatase levels.
• Biochemical analysis of an osteoarthritis model to compare with human disease.
• In vitro testing of EDTA as a chelator of metallic cations to inhibit enzyme activity.

Main Results:

• Neutral proteoglycanase and collagenase levels correlated with OA severity.
• Acid phosphatase, a lysosomal enzyme marker, also showed correlation with disease severity.
• Articular cartilage collagenase activity is inhibited in normal cartilage but active in OA, and is not a lysosomal enzyme.
• The studied OA model exhibited a biochemical profile similar to human OA.
• EDTA significantly reduced degradative enzyme activity and modified the arthritic process in the model.

Conclusions:

• Enhanced degradative enzyme activity, particularly neutral proteoglycanase and collagenase, is a key factor in osteoarthritis cartilage matrix loss.
• EDTA demonstrates potential as a therapeutic agent by inhibiting these degradative enzymes and impacting the disease progression.